Diclazuril: A Potent Antiparasitic for Animal Health

Discover the efficacy of Diclazuril in combating coccidiosis and EPM, ensuring healthier livestock and horses.

Get a Quote & Sample

Key Advantages

Broad-Spectrum Efficacy

Diclazuril provides broad-spectrum anticoccidial activity, effectively targeting various Eimeria species, essential for preventing coccidiosis in poultry and rabbits.

EPM Treatment for Horses

The drug is a critical component in treating Equine Protozoal Myeloencephalitis (EPM), offering a solution for neurological issues in horses.

Safety Profile

Diclazuril demonstrates high safety at therapeutic doses, minimizing toxicity concerns for treated animals.

Key Applications

Poultry Coccidiosis Prevention

Utilize diclazuril for poultry coccidiosis prevention, safeguarding broiler chickens and other fowl from parasitic infections.

Rabbit Coccidiosis Management

Implement diclazuril for rabbit coccidiosis management, crucial for maintaining health in intensive rabbit farming environments.

Equine Protozoal Myeloencephalitis (EPM) Treatment

Administer diclazuril as a treatment for EPM in horses, addressing a significant neurological concern in equine health.

Veterinary Pharmaceutical Raw Material

Diclazuril serves as a key veterinary pharmaceutical raw material, forming the basis for various anticoccidial and antiparasitic formulations.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).